Press release
Carotid Artery Disease Market 2018 Breaking Down into Type, Treatment, Region & Key Players – Forecast to 2023
The “Global Carotid Artery Disease Market Research Report 2018” is the latest comprehensive analysis document assists the reader to build effective business strategies. This report provides an in-depth insight covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis.Market Highlights:
The global carotid artery disease market is expected to witness positive growth during the forecast period. The carotid artery disease is a condition in which plaques are developed in arteries that supply blood to the brain which further leads to stroke. The plaque may be composed of fat, cholesterol, calcium, and other blood constituents. The disease is caused due to smoking, high levels of certain fats and cholesterol in the blood, high blood pressure, diabetes or insulin resistance, lack of physical activity, and aging. The carotid artery disease market is expected to witness tremendous growth owing to the rise in cigarette smoking. According to the Centers for Disease Control and Prevention in 2016, more than 37.8 million adults smoke cigarettes in the US. Other key factors such as rising blood fat levels among the population, increasing geriatric population, growing prevalence of diabetes, increasing obesity, growing number of high blood pressure patients, and sedentary lifestyle are contributing towards the growth of the market.
However, factors such as high cost of diagnostics and surgeries, huge initial investments, and associated risks of cardiovascular drugs and surgeries are expected to restrict the market growth during the forecast period.
Get Premium Sample Report @ https://www.marketresearchfuture.com/sample_request/6301
Top Players in Carotid Artery Disease Market:
Cordis Corporation (US), Medtronic (US), Silk Road Medical Inc. (US), InspireMD Inc., Boston Scientific Corporation (US), C.R. Bard, Inc. (US), Cook Medical (US) and W.L. Gore & Associates (US) and Abbott Vascular, Inc. (US), and others.
Market Segmentation of Carotid Artery Disease Market:
The global carotid artery disease market is segmented on the basis of diagnosis, treatment, and end-user. The diagnosis category includes physical exam, computed tomography angiography, carotid angiography, magnetic resonance angiography, and carotid ultrasound. The treatment segment is further segmented into medications and surgical procedures. The medications category includes aspirin, clopidogrel, and others. Surgical procedures are categorized into carotid endarterectomy, carotid artery angioplasty, and carotid artery stenting. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, pharmacies, and others.
On the basis of region, the global carotid artery disease market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Intended Audience:
• Pharmaceutical companies
• Biotechnological institutes
• Government and private laboratories
• Research and Development (R&D) companies
• Medical research laboratories
• Market research and consulting service providers
Regional Analysis of Carotid Artery Disease Market:
The carotid artery disease market is dominated by North America owing to the rising prevalence of stroke. According to the facts and statistics about the stroke of the Centers for Disease Control and Prevention 2017, each year 795,000 people in the United States have a stroke. Other factors such as increasing healthcare expenditure and increasing geriatric population within the population drive the market growth in this region.
It is estimated that Europe stood second in the global carotid artery disease market owing to increasing research and funds for stroke as the prevalence of stroke is increasing in the European region. For instance, the European Stroke Organization (ESO) supports/endeavors programmes to reduce the burden of stroke. It promotes the Horizon 2020 Projects, the largest EU Research, and Innovation programme, which will benefit the stroke community. Such extensive research activities influence the growth of this market in this region.
Increasing prevalence of high blood pressure within this region also drives the market growth in this region. According to the European Society of Hypertension and the European Society of Cardiology, 30 to 45% people in Europe suffer from hypertension. Thus, increasing prevalence of hypertension in this region influences the growth of the market.
Asia-Pacific was projected to be the fastest growing region for the global carotid artery disease market in 2017. The market is expected to witness growth owing to the rising geriatric population. The Asian Development Bank projected that Asia’s geriatric population is expected to reach 923 million by 2050. This provides a favorable background for the market to grow.
The Middle East and Africa holds the least share in the global carotid artery disease market due to the presence of stringent government policies and poor economies. However, the market is expected to witness growth due to the high incidence of cardiovascular disease, government support, and rapid urbanization and infrastructure development in the Middle East. Other growth factors such as hypertension, diabetes, obesity, and high cholesterol within the region contribute to the market growth.
Need More Information Ask to our experts @ https://www.marketresearchfuture.com/enquiry/6301
Major Points form TOC for Carotid Artery Disease Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Carotid Artery Disease Market, By Diagnosis
Chapter 7. Global Carotid Artery Disease Market, By Treatment
Chapter 8 Global Carotid Artery Disease Market, By End User
Chapter 9. Global Carotid Artery Disease Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
TOC Continued….!
Get Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/6301
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carotid Artery Disease Market 2018 Breaking Down into Type, Treatment, Region & Key Players – Forecast to 2023 here
News-ID: 1226729 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…